Respiratory Infections

Respiratory diseases remain the world’s most deadly communicable disease1. While most respiratory infections can resolve on their own, some infections, such as COVID-19 disease can be a serious threat for infants, the elderly, and the immunocompromised. 

1. The top 10 causes of death (
Learn More


Since the start of the COVID-19 pandemic, testing has proven to be key to enabling restrictions to be eased. Even entering the endemic phase, routine testing and surveillance for SARS-CoV-2 remain important.

Traditional PCR tests performed in a central lab are very accurate, but take a considerable time to complete, and rapid antigen tests are fast but lack sensitivity and accuracy2.
This has driven the demand for rapid decentralized PCR testing, performed in satellite laboratories at the point of care or in locations where there is a need for on-demand testing, like ICUs /ED settings in hospitals etc.
2. Lee J, Song JU, Shim SR. Comparing the diagnostic accuracy of rapid antigen detection tests to real time polymerase chain reaction in the diagnosis of SARS-CoV-2 infection: A systematic review and meta-analysis. J Clin Virol. 2021;144:104985. doi:10.1016/j.jcv.2021.104985
Our Solution

PCR test delivering accurate results in less than 20 minutes.

Enabled by its silicon chip technology, our ultra-fast COVID-19 PCR Test combines the speed of a rapid antigen test with the performance of trusted PCR-based testing.

Within 20 minutes of registering on site, patients receive their result, with the real-time PCR itself taking less than 12 minutes.

The clinical performance study in Europe has demonstrated that the miDiagnosticsTM COVID-19 Test is highly sensitive (95,5%) and specific (94,9%) in the general population, rising to 98.6% and 96.5% respectively in symptomatic patients3.

miDiagnosticsTM COVID-19 Test is CE-IVD marked and recently gained CTDA approval. It is not FDA-cleared. The test is for professional use only.

3. Bos DAG, Lagrou K, Verbakel JY. Prospective Performance Evaluation of the miDiagnostics COVID-19 PCR Test for Rapid SARS-CoV-2 Detection on Nasopharyngeal Swabs. J Clin Microbiol. 2023;61(5):e0187122. doi:10.1128/jcm.01871-22
How it works

How it works.

Swab Sample

Validated for use with nasopharyngeal and oropharyngeal dry swabs.

PCR Card

A small volume of the sample (5µl) is placed on the disposable PCR Card containing the silicon chip.


The multiple use, portable reader performs the temperature cycling and optical detection, processes data and communicates the test result.

Key Benefits.


Unique silicon chip technology allowing for ultra-fast PCR


Built-in controls ensure the highest quality result


<12 minutes for real-time PCR


Closed reaction chamber limits risk of contamination


High clinical performance with 98% accuracy


Platform compatible with various tests

Want to order?
T. +32 (0)16 360 596

Customer documentation

Download Center

For more information, please contact us at or view our downloadable PDF.

View Test Clinical Performance Publication